The successful applicant will be committed to excellence in research, teaching, and service, and will be expected to teach undergraduate and/or graduate courses, build and lead a team of researchers, including student researchers, implement a program of externally funded research that yields top-tier publications, contribute a distinctive scientific or engineering capability to the IMPRINT HLA-Peptide Biotherapeutics Program, collaborate across the cluster where appropriate, and contribute to professional service within UTA and the external community. The program leverages UTA's growing strengths in translational immunology, advanced biomanufacturing, analytical sciences, computational biology, and precision medicine, as well as strategic partnerships with Cook Children's Health Care System, Baylor Scott & White Health, Baylor University Medical Center, regional biotechnology partners, and the National Center for Therapeutics Manufacturing 2 (NCTM2).